CLDN1 Increases Drug Resistance of Non-Small Cell Lung Cancer by Activating Autophagy via Up-Regulation of ULK1 Phosphorylation

BACKGROUND: The aim of this study was to investigate the expression of CLDN1 in non-small cell lung cancer (NSCLC) and its mechanism of action in cisplatin resistance. MATERIAL/METHODS: A total of 55 patients with NSCLC admitted to our hospital between October 2013 and October 2015 were included. NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhenhuan, Li, Jing, Jiang, Yan, Xu, Wen, Li, Xin, Jing, Weili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479443/
https://www.ncbi.nlm.nih.gov/pubmed/28614291
http://dx.doi.org/10.12659/MSM.904177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479443/
https://www.ncbi.nlm.nih.gov/pubmed/28614291
http://dx.doi.org/10.12659/MSM.904177

Ejemplares similares